BioSpace News Archive

BioMidwest

Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher

The winner, Dr. Andreas Behren received the grand prize-a 40,000 USD research grant-at a well-attended reception at Madame Tussauds in Washington DC on November 13, 2017.

November 14, 2017

·

5 min read

ITL BioMedical Launches ITL Clinical; a New Brand to Target Hospital and Clinical Markets

ITL BioMedical is pleased to announce the launch of a new global brand, ITL Clinical, that will feature ITL products that serve the hospital and clinical markets.

November 14, 2017

·

2 min read

Business

Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology

The collaborators plan to initiate a randomized, placebo-controlled clinical study at MD Anderson, sponsored by the Parker Institute, in patients with advanced metastatic melanoma.

November 14, 2017

·

8 min read

Drug Development

TapImmune Completes Patient Enrollment Ahead of Schedule in Phase II Cancer Vaccine Study for Treating Triple-Negative Breast Cancer

The comprehensive four-arm study is designed to help determine the optimal vaccine dose and regimen to maximize the immune response generated against the vaccine’s molecular target, FRa.

November 14, 2017

·

5 min read

Drug Development

Medicenna Presents Clinical Data From Previous Phase I and II Clinical Trials of MDNA55

The poster presentation by Dr. Bexon provides an overview of the safety and efficacy results from previous Phase I and II clinical trials of the targeted immunotherapy, MDNA55, in 66 patients with recurrent glioblastoma, the most common and deadly form of brain cancer.

November 14, 2017

·

4 min read

Drug Development

Novartis Presents New Data at SABCS Across Broad Range of Breast Cancer Patient Populations, Combination Treatments and Lines of Therapy

Results from the Phase III MONALEESA-7 trial in premenopausal women with hormone-receptor positive, HR+/HER2-) advanced or metastatic breast cancer will be presented for the first time in a late-breaker oral presentation.

November 14, 2017

·

8 min read

Biotech Beach

CSD Labs Release: Clinical Studies of Advanced eMurmur Auscultation Technology Presented at AHA Scientific Sessions 2017

Preliminary results from this partial dataset demonstrated that eMurmur ID’s sensitivity and specificity for automated detection of pathologic murmurs were 84.4% and 85.9%, respectively, versus sensitivity and specificity of 68.9% and 57.7%, respectively, for the first generation SensiCardiac device.

November 14, 2017

·

3 min read

BioCapital

Epidarex Capital Portfolio Company Apellis Pharmaceuticals Completes IPO

Epidarex and its predecessor fund, MASA Life Science Ventures, were among the company’s earliest backers, funding the development of the company’s core technology shortly after its spin-out from the University of Pennsylvania.

November 14, 2017

·

2 min read

New Study Demonstrates Significant Clinical Workflow and Staff Experience Benefits of Philips’ Azurion Image-Guided Therapy Platform

Royal Philips today announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion.

November 14, 2017

·

4 min read

Drug Development

Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH With its Oral Insulin Capsule

Oramed plans on initiating the study in the coming month.

November 14, 2017

·

4 min read